Press release
Kidney Cancer Drugs Market- several novel molecules receiving approval globally is fuelling the market growth
According to the report, the global kidney cancer drugs market is currently driven by multiple factors. At the top of this list is the growing number of patients that are afflicted with kidney cancer. Citations made in the report include findings by the World Cancer Research Fund International, which stated that by 2012, there were over 338,000 new cases of kidney cancer registered. Also known as renal cell carcinoma, kidney cancer constitutes 85% of the kidney-related tumors.
Download exclusive Sample of this report: http://tinyurl.com/hmarsyu
The report also includes discussions on the introduction of novel molecules into mainstream medicine after their approval as a cancer treatment method and the impact it will have on the global kidney cancer drugs market in the near future.However, the global kidney cancer drugs market is continually hampered by high drug prices, especially in case of branded drugs. Consequently, most consumers are turning to generic kidney cancer drugs, which is restraining the market’s growth rate.
New manufacturing trends in the global kidney cancer drugs market reveal that top players are shifting focus towards the developing economies and their emerging markets. Companies hope the new markets will open up sales of their kidney cancer drugs owing to the high population density of countries such as China and India.Key players in the global kidney cancer drugs market are GlaxoSmithKline, Novartis AG, and Pfizer. The report notes that over 40% of the global kidney cancer drugs market in 2013 was held by Pfizer, due to patent monopoly in branded kidney cancer drugs.
View exclusive Global strategic Business report :
http://www.transparencymarketresearch.com/kidney-cancer-drugs-market.html
The report explains the growth rate in the global kidney cancer drugs market, with key focus on various drugs in it, including Nexavar, Afinitor, Sutent, Torisel, Proleukin, Inlyta, Avastin, and Votrient. Of these, Sutent held over 30% of the global kidney cancer drugs market. Sutent is the marketed version of Sunitinib, Pfizer’s drug in the global kidney cancer drugs market. It is the most-preferred drug in the market for now. Sutent is expected to exhibit at a low CAGR of 2.1% from 2016 to 2020, owing to its high price. On the other hand, Votrient is expected to exhibit a fast growth rate. It has already recorded a CAGR of 41.7% between 2012 and 2016.
The report also provides details on the major pipeline drugs in the global kidney cancer drugs market, including Dovitinib and Opdivo.Geographically, the global kidney cancer drugs market is led by North America, which held 45% of the market in 2013. A 6.0% CAGR is attributed to Asia Pacific owing to increasing demand for kidney cancer drugs in the region’s rapidly developing economy and increase in focus by top players on the region.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Drugs Market- several novel molecules receiving approval globally is fuelling the market growth here
News-ID: 392724 • Views: …
More Releases from TMR – Research Reports
Power Line Communication Market to Present Highly Lucrative Opportunities for Ma …
Power Line Communication (PLC) is an emerging communication technology which enables data exchange over existing power cables. It uses power grids to communicate between two end-points. PLC technology allow users to control or retrieve data in a half-duplex manner. Furthermore, in this communication method, sender modulates the data, and injects in power cables which can be retrieved by de-modulation at the receiving end. PLC technology is widely used for home…
Wood Coatings Market - Roof coatings to Register High Demand | 2025
The global wood coatings market is choc-o-bloc with players and this has served to intensify the competition over the years. Product differentiation is a key tool leveraged by players to steal a march over their competitors. Key factors promoting growth in the market are the soaring construction activities across the globe and the increasing spending capacity of people which has stoked sales of furniture.
Another factor catalyzing growth in the global…
Welding Materials Market - Thriving Growth In Industrial Application Segments By …
The global welding materials market is growing on account of the thriving growth of application segments such as transportation, building and construction, marine, and automobiles. The growing urbanization in developing nations will drive the growth of this market. The increasing infrastructure development in Asia Pacific will also fuel the growth of the welding materials market. The technological advancements in the automobile industry will also aid the growth of this market.…
Intumescent Coatings Market Demand for Improved Fire Safety to Fuel Growth By 20 …
The global intumescent coatings market has remained moderately concentrated as nearly 45% of its overall share was held by three enterprises in 2015. These companies were Sherwin-Williams Co., PPG Industries Inc., and Nobel N.V., finds Transparency Market Research (TMR) in a new study. These companies, besides other prominent market players are continuously making efforts to expand their regional footprint by establishing new manufacturing units.
While expanding operations across emerging nations has…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
